Shots:
- Insilico has entered into a multi-target strategic alliance with Bora to combine its Pharma.AI platform with Bora’s expertise in drug development, manufacturing, quality, & commercialization
- Insilico will provide end-to-end AI solutions and R&D strategies to accelerate Bora’s AI- & automation-driven drug discovery & development, with plans to expand AI across development planning, process optimization, pharmaceutical development, manufacturing readiness, & quality systems
- If fully implemented, the alliance could exceed $2.5B. Insilico will support Bora in expanding AI capabilities & workforce AI literacy while applying AI to improve manufacturing, supply chain, distribution, & corporate operations, with the partnership scope to be further refined
Ref: PRnewswire | Image: Insilico Medicine & Bora Pharma | Press Release
PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com
